Citation only
via Europe PMC
Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment.
Mo XY, Huang D, Han SF, Tai GJ, Xu M.
Current medical science · 2026
Abstract
The accelerating aging of the global population has made aging and its related diseases major public health challenges in the 21st century. Adipose tissue is not only an energy reservoir but also a crucial endocrine organ and metabolic regulator. Its dysfunction is closely linked to aging and the development of multiple diseases. This review outlines the key characteristics of adipocyte senescence(definition) and discusses its pathological contributions to obesity, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and cardiovascular diseases. It also summarizes current intervention strategies for adipocyte senescence, including senolytics(definition), senomorphics, caloric restriction(definition), physical exercise, and gene editing. We propose lipid prodrugs as promising adipose tissue delivery platforms that can be coupled with diverse therapeutic agents to increase the local concentration of drugs and minimize systemic toxicity. By utilizing the unique lipid metabolism of adipocytes, this strategy offers a new avenue for therapeutic intervention in adipocyte senescence and its associated metabolic disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11596-026-00251-3
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
XY, M., D, H., SF, H., GJ, T., & M., X. (2026). Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment. <em>Current medical science</em>. https://doi.org/10.1007/s11596-026-00251-3
Vancouver
XY M, D H, SF H, GJ T, M. X. Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment. Current medical science. 2026. doi:10.1007/s11596-026-00251-3.
BibTeX
@article{mo2026Interv,
title = {Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment.},
author = {Mo XY and Huang D and Han SF and Tai GJ and Xu M.},
journal = {Current medical science},
year = {2026},
doi = {10.1007/s11596-026-00251-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2022
Open access · CC-BY
Cardiovascular Inflammaging: Mechanisms and Translational Aspects
European Respiratory Journal 2026
Open access · CC-BY
Hallmarks of the ageing lung: 10 years later
The European respiratory journal 2026
Open access · OA
Hallmarks of the ageing lung: 10 years later.
Biochemical Pharmacology 2012
Preprint · OA
Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence
Mechanisms of ageing and development 2024
Citation only
Adipose tissue senescence: Biological changes, hallmarks and therapeutic approaches.
Hepatology communications 2026
Open access · OA